The World Health Organization has reported the incidence rate of mantle cell lymphoma globally as 0.5 cases per 100,000 people. Mantle cell lymphoma possess an aggressive disease etiology that usually commences with the enlargement of lymph node and progress to metastasis to other organs such as bone marrow, gastrointestinal tract, and liver.
Patient monitoring devices studied for the scope of the report consists of various products and applications. Rising prevalence of chronic diseases such as cardiovascular diseases, diabetes and obesity, increasing number of geriatric population suffering with respiratory diseases. Increasing number of surgical procedures performed and rising inclination towards healthcare monitoring devices and apps to maintain healthy lifestyle has resulted in the deep market penetration for the patient monitoring devices.
Surgical mesh is a medical device constructed by using synthetic materials or animal tissue and used to provide extra support to weak or damaged tissue. Surgical polypropylene mesh widely adopted in the market due to its stability, durability, low infection risk and high mechanical strength.
The development of capsule endoscopy in 2001 has given gastroenterologists the opportunity to examine the gastrointestinal tract in a non-invasive manner. Capsule endoscopy is a digital healthcare technology that can be utilized to detect gastrointestinal disorders such as gastroparesis, esophageal disease, gastrointestinal bleeding, and colon related diseases, followed by Crohn’s disease and polyposis syndrome. Capsule endoscopy has revolutionized the diagnosis of various parts of the GI system in a very simple manner. Medical professional can gain edge in observing the various parameters of gastrointestinal tract such as temperature, pressure, and pH with the help of capsule endoscopes.
Sterile injectables market is rising with growing demand for biologics in order to treat numerous medical conditions with immediate and effective outcomes. Widening application of injectables have transformed medical treatments as higher quality of sterile injectables have lowered chances of risk or any contamination.
Cryoablation procedure, a minimally invasive procedure performed to destroy cells by deploying cold temperature. It is very well-known technology for efficient destruction of cells while keeping surrounding tissues intact. This fast, cost-effective solution is gaining popularity especially in medical oncology and cardiology area majorly due to lesser side-effects rather than conventional approaches.
Vaccines plays a significant role in prevention and control of different forms of infectious diseases. In the previous years, killed or attenuated vaccines were used, while gradually transitioning to recombinant subunit approach in the last two decades.
The report titled “Wearable Injector Devices Market: Growth, Future Prospects, and Competitive Analysis, 2021 -2029” offers strategic insights into the overall wearable injector devices market along with the market size and estimates for the duration 2019 to 2029.
Growing prevalence of chronic diseases, particularly in the geriatric population, significant advancement in lasers in terms of safety and outcomes, growing demand for cosmetic interventions and minimally invasive ophthalmic procedures are the major drivers of the global surgical lasers market. The advent and surge in demand for non-invasive and minimally invasive surgeries has been a key attribute supporting the growth of this market.
The photopheresis products market is expected to grow at a compound annual growth rate of 6% during the forecast period.The market for photopheresis products is projected to expand as the incidence of autoimmune disorders and the number of organ transplants rise. Photopheresis is a medical treatment that separates white blood cells using a device. Before the patient receives the blood, such white cells are subjected to an 8-methoxy psoralen therapy, followed by UVA irradiation. These white cells are the root cause of sickness.The US Food and Drug Administration has approved photopheresis, commonly known as extracorporeal photopheresis (ECP), for the treatment of cutaneous T-cell lymphoma.
The oncology drugs market is a critical segment of the pharmaceutical industry, providing innovative solutions for the treatment of cancer. The market is driven by the increasing prevalence of cancer worldwide, advancements in technology, and the emergence of personalized medicine. The oncology drugs market is a highly competitive and dynamic market, with many companies focusing on the development of novel therapies to treat cancer. One of the primary drivers of the oncology drugs market is the increasing prevalence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, accounting for approximately 9.6 million deaths in 2018. The rising incidence of cancer has led to an increased demand for innovative oncology drugs, driving the growth of the market.
The global oncology drugs market is expected to grow at a CAGR of 13% during the period of 2023 to 2031. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the oncology drugs market is the increasing use of immunotherapy. Immunotherapy involves the use of drugs that stimulate the body's immune system to attack cancer cells. Immunotherapy has shown promising results in the treatment of several types of cancer, including melanoma, lung cancer, and bladder cancer. The development of immunotherapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the oncology drugs market. Another trend in the oncology drugs market is the increasing focus on precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of the oncology drugs market.
The increasing focus on targeted therapies is also driving the growth of the oncology drugs market. Targeted therapies are drugs that are designed to target specific molecules that are involved in the growth and spread of cancer cells. Targeted therapies can be more effective than traditional chemotherapy, as they have fewer side effects and are more specific in their action. The development of targeted therapies requires the use of advanced drug discovery technologies, which has contributed to the growth of the oncology drugs market.
The increasing use of combination therapies is driving the growth of the oncology drugs market. Combination therapies involve the use of two or more drugs to treat cancer. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the oncology drugs market. The oncology drugs market is a critical segment of the pharmaceutical industry, providing innovative solutions for the treatment of cancer. The increasing prevalence of cancer worldwide, advancements in technology, and emerging trends in immunotherapy, precision medicine, targeted therapies, and combination therapies are expected to drive the growth of the oncology drugs market. As the demand for new and effective therapies continues to increase, the oncology drugs market is expected to remain a critical component of the pharmaceutical industry in the coming years. Companies that provide oncology drugs and related services are well-positioned to capitalize on this growing market.
